A recent study indicates that anti-CD90 therapy, using its antibody-mediated, water-soluble CdSe core nanocrystals loaded with photosensitizers, specifically killed CD90-positive leukemia CSCs (Bakalova et al., 2004). Here, THY1 is linked to leukemia.